Product review · Updated September 30, 2026
Medik8 Liquid Peptides Advanced MP review: keeping the current serum separate from the original
The current US Advanced MP formula names Copper Palmitoyl Heptapeptide-14; its advertised complex differs from the original Liquid Peptides presentation.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Medik8’s Liquid Peptides Advanced MP Face Serum needs its full name attached to the review. A second US manufacturer record describes original Liquid Peptides. Both mention copper peptides and a 30% complex or blend, but their titles and advertised peptide counts differ. Shortening them to Liquid Peptides can hide which product’s declaration was actually examined.
Facework read the retained current and original US records captured September 30, 2026. The current Advanced MP extraction contains a complete ingredient list; the original extraction does not. We have not tested either serum or evaluated their full study reports. This account keeps product identity, formula disclosure and merchant claims separate for readers researching mature facial skin.
In this article
Advanced MP is part of the product identity
The current US product page repeatedly names Liquid Peptides Advanced MP Face Serum. Advanced MP is not an optional editorial abbreviation: it distinguishes the target under review. The same page has a question that separately names the original Liquid Peptides formula, reinforcing the need to retain the qualifier.
The cream-and-serum comparison gives this serum a broader reading context without turning it into a cream. Our review follows the US Advanced MP record rather than a general Medik8 brand description. It makes no claim about an Australian version, an earlier package or another product whose name shares the words Liquid Peptides. Those would need their own exact documentation before their formulas were incorporated into this account.
The copper name comes from the current full list
The Advanced MP declaration names Copper Palmitoyl Heptapeptide-14. That is the copper entry we report, including its number and additional words. The current full list provides a firmer basis for describing this target than substituting a shorter copper name or inheriting an ingredient from an older product discussion.
The Drunk Elephant review is another product account available in the library. Its link is a reading connection, not a statement that finished products are interchangeable. Here, the copper classification rests on the Advanced MP list itself. We have not analytically identified the contents of a delivered bottle, measured ingredient purity or established an ingredient-specific outcome. A declared name supports identity at the level of the manufacturer record.
Thirty percent describes a multi-peptide complex
The current page advertises a 30% Multi-Peptide Complex and describes 13 peptides. The object attached to the percentage is the complex. The object attached to the count is peptides generally. Reporting either as a measured amount of the named copper ingredient would change the meaning of the manufacturer wording.
The percentage-label guide examines why the noun beside a percentage matters. This review does not calculate a copper fraction from the complex, divide it by the number of peptides or infer that all 13 entries have equal amounts. None of those results is supplied by the accepted declaration. The complex statement is a merchant description of the formula, without an assay performed or reviewed by Facework.
The original Liquid Peptides record has its own limits
The original US Liquid Peptides extraction advertises 10 peptides in a 30% blend. That differs from the current Advanced MP page’s 13-peptide presentation. We attribute both numbers rather than turning their difference into a claim that one product is stronger, more effective or clinically preferable.
The original extraction has a Full Ingredients heading without the full declaration beneath it. It therefore cannot substitute for the current Advanced MP list or prove a detailed ingredient-by-ingredient reformulation. The distinction we can establish is narrower: two separately named manufacturer records with different advertised counts. That is enough to prevent a legacy description from being silently attached to the current review target, while leaving unreturned legacy formula details unresolved.
Other peptide names remain separate components
The current complete list includes Palmitoyl Tripeptide-38, Palmitoyl Tripeptide-5, Tetrapeptide-21 and Pentapeptide-18 among its separate entries. Heptapeptide-15 Palmitate also appears, as do Carnosine and Arginine/Lysine Polypeptide. We preserve these written names without treating every component as another copper ingredient or assigning it an isolated effect.
The NEOVA Power Defense review supplies another product-specific discussion to read. It does not complete missing Advanced MP measurements. The moisturizer-role guide considers format questions separately. A full serum declaration can describe a complex mixture while still leaving texture experience, ingredient delivery and a reader’s preferred finished product outside the observations made for this review.
Packaging and region warnings qualify the web formula
Medik8’s ingredient warning allows for product upgrades and slight regional variations based on local laws. It identifies the ingredient list printed on the package as definitive. The warning belongs beside the current US declaration rather than in a footnote that readers could mistake as irrelevant to product identity.
The package-record guide discusses that distinction between a saved page and a received item. We did not compare the Advanced MP list with a bottle, inspect every region or establish a particular batch version. The warning does not prove that a reader’s package differs. It explains why the exact US web record cannot be treated as a complete examination of every unit sold under a related product name.
A precise version account leaves performance open
The Advanced MP record gives us a current US serum identity, a named copper declaration and a complete online formula. The original record adds meaningful context about a separately named version, with a missing returned full list of its own. Neither document is a product trial conducted by this review.
For mature facial skin, those distinctions help prevent a reader from evaluating the wrong description. They do not determine the response to either finished serum. We have not compared clinical performance, measured delivery or verified an injectable alternative. The supported account ends with the actual version and declaration, while the manufacturer’s product claims remain claims and the package warning remains attached to the formula.
Sources behind this reading
- Liquid Peptides Advanced MP Face Serum | Medik8 US ↗Official complete current product ingredient declaration and format · Checked September 30, 2026
- Original Liquid Peptides | Medik8 US ↗Official original-version product context; not a current complete ingredient declaration · Checked September 30, 2026